Back
Regeneron Pharmaceuticals Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
44
REGN
Regeneron Pharmaceuticals
Last Price:
$537.99
Seasonality Move:
8.46%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
The current trend is relatively stagnant and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
Regeneron Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 529.95 | Buy |
| 20-day SMA: | 519.67 | Buy |
| 50-day SMA: | 552.25 | Sell |
| 200-day SMA: | 721.27 | Sell |
| 8-day EMA: | 532.93 | Buy |
| 20-day EMA: | 529.84 | Buy |
| 50-day EMA: | 551.61 | Sell |
| 200-day EMA: | 690.73 | Sell |
Regeneron Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.14 | Sell |
| Relative Strength Index (14 RSI): | 56.41 | Buy |
| Chaikin Money Flow: | -374814 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (493.21 - 543.01) | Buy |
| Bollinger Bands (100): | (532.4 - 667.92) | Sell |
Regeneron Pharmaceuticals Technical Analysis
| Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Regeneron Pharmaceuticals Stock
Is Regeneron Pharmaceuticals Stock a Buy?
-
Regeneron Pharmaceuticals share price is 547.36 while REGN 8-day simple moving average is 529.95, which is a Buy signal.
-
The stock price of REGN is 547.36 while Regeneron Pharmaceuticals 20-day SMA is 519.67, which makes it a Buy.
-
Regeneron Pharmaceuticals 50-day simple moving average is 552.25 while REGN share price is 547.36, making it a Sell technically.
-
REGN stock price is 547.36 and Regeneron Pharmaceuticals 200-day simple moving average is 721.27, creating a Sell signal.
REGN Technical Analysis vs Fundamental Analysis
Sell
44
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a SellThe current Regeneron Pharmaceuticals [REGN] share price is $547.36. The Score for REGN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Regeneron Pharmaceuticals Stock Info
Market Cap:
59.1B
Price in USD:
547.36
Share Volume:
456.4K
Regeneron Pharmaceuticals 52-Week Range
52-Week High:
1,211.20
52-Week Low:
476.49
Sell
44
Regeneron Pharmaceuticals (REGN)
is a Sell
Regeneron Pharmaceuticals Share Price Forecast
-
What is the Regeneron Pharmaceuticals stock price today?The Regeneron Pharmaceuticals stock price is 547.36 USD today.
-
Will REGN stock go up or go down?Regeneron Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Regeneron Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regeneron Pharmaceuticals is overvalued.
Is Regeneron Pharmaceuticals Stock a Buy?
-
Regeneron Pharmaceuticals share price is 547.36 while REGN 8-day exponential moving average is 532.93, which is a Buy signal.
-
The stock price of REGN is 547.36 while Regeneron Pharmaceuticals 20-day EMA is 529.84, which makes it a Buy.
-
Regeneron Pharmaceuticals 50-day exponential moving average is 551.61 while REGN share price is 547.36, making it a Sell technically.
-
REGN stock price is 547.36 and Regeneron Pharmaceuticals 200-day simple moving average is 690.73, creating a Sell signal.
Fundamental Analysis of Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $2.15 per share, an increase next quarter of $0.68 per share, a decrease this year of $9.47 per share, and an increase next year of $4.28 per share.
Technical Analysis of Regeneron Pharmaceuticals
Should I short Regeneron Pharmaceuticals stock?
-
REGN Moving Average Covergence Divergence (MACD) indicator is -3.14, suggesting Regeneron Pharmaceuticals is a Sell
-
Regeneron Pharmaceuticals Relative Strength Index (RSI) is 56.41, which suggest Regeneron Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Regeneron Pharmaceuticals is (493.21 - 543.01), which suggest Regeneron Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Regeneron Pharmaceuticals is (532.4 - 667.92), which suggest Regeneron Pharmaceuticals is a Sell
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.